TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Pot Stock Tilray Just Had One of the Most Mind-Blowing Sessions Ever
Play
INVESTING

Tilray, Aurora, Cannabis Stocks Surging on Deals and Reddit Boost

Inovio Lead
INVESTING

Inovio Soars as Reddit Crowd Takes Notice, BlackRock Boosts Stake

Novavax Lead
INVESTING

Novavax, Siebert Financial: 5 Top Stock Gainers for Friday

PRESS RELEASES

INOVIO Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Inovio Lead
INVESTING

Inovio Falls After $150 Million Share Offering Unveiled

PRESS RELEASES

INOVIO Announces Pricing Of Public Offering Of Common Stock

PRESS RELEASES

INOVIO Announces Proposed Public Offering Of Common Stock

PRESS RELEASES

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment Of Precancerous Vulvar Dysplasia Caused By HPV-16/18

PRESS RELEASES

INOVIO Announces Publication Of Phase 1 Data From Its COVID-19 DNA Vaccine Candidate, INO-4800 In The Lancet's EClinicalMedicine

PRESS RELEASES

INOVIO And Advaccine Announce First Dosing Of Subject In Phase 2 Clinical Trial For COVID-19 DNA Vaccine Candidate INO-4800 In China

PRESS RELEASES

INOVIO Doses First Subject In Phase 2 Segment Of Its INNOVATE Phase 2/3 Clinical Trial For INO-4800, Its DNA Medicine To Prevent COVID-19

PRESS RELEASES

INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition Of Kaneka Eurogentec S.A.

PRESS RELEASES

INOVIO Announces Dosing Of First Subject In Phase 1/2 Clinical Trial For INO-3107, Its DNA Medicine To Treat A Rare Disease Recurrent Respiratory Papillomatosis (RRP)

An employee of SinoVac works in a lab at a factory producing its SARS CoV-2 Vaccine for COVID-19 named CoronaVac in Beijing on Thursday, Sept. 24, 2020. Photo: AP
INVESTING

Coronavirus Vaccine Trials Latest Updates: Moderna, Inovio

Inovio Lead
INVESTING

Inovio Jumps on Progress of Coronavirus Vaccine Candidate

PRESS RELEASES

INOVIO Announces Initiation Of Phase 2 Segment Of Its Phase 2/3 Clinical Trial For Its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded By The U.S. Department Of Defense

Inovio Lead
EARNINGS

Inovio Sees FDA Decision This Month on Vaccine Trial Resumption

Dow Futures Lead
MARKETS

Pfizer, Biden, Biogen, Beyond Meat - 5 Things You Must Know Monday

Stock Market Lead
JIM CRAMER

Game Plan: Cramer's 'Mad Money' Recap (Friday 11/6/20)

PRESS RELEASES

INOVIO To Report Third Quarter 2020 Financial Results On November 9, 2020

Hong Kong Health Experts Say Delay To AstraZeneca Vaccine Effort Will Not Hinder Government Plans To Secure Covid-19 Shots
INVESTING

AstraZeneca Allowed to Resume Covid Vaccine Trial in U.S.

Hong Kong Health Experts Say Delay To AstraZeneca Vaccine Effort Will Not Hinder Government Plans To Secure Covid-19 Shots
Video

Coronavirus Update: FDA Puts Inovio Trial on 'Partial Clinical Hold'

  • Sep 28, 2020 3:09 PM EDT
Hologic, Marks & Spencer and Sensata Set to Enjoy Strong Growth
INVESTING

Hologic Gets FDA Authorization for Asymptomatic Covid Test

Inovio Lead
INVESTING

Inovio Shares Plunges After FDA Puts Partial Hold On Coronavirus Vaccine Trial

PRESS RELEASES

INOVIO Reports FDA Partial Clinical Hold For Planned Phase 2 / 3 Trial Of COVID-19 Vaccine Candidate INO-4800